AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 132 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,966,168 | +21.2% | 1,724,274 | -2.7% | 0.00% | – |
| Q2 2023 | $1,622,273 | +72.1% | 1,772,977 | +5.4% | 0.00% | – |
| Q1 2023 | $942,871 | +97103.2% | 1,682,498 | 0.0% | 0.00% | – |
| Q4 2022 | $970 | -99.8% | 1,682,498 | +3.7% | 0.00% | – |
| Q3 2022 | $512,000 | -10.3% | 1,621,825 | +0.3% | 0.00% | – |
| Q2 2022 | $571,000 | -74.8% | 1,617,393 | -48.7% | 0.00% | – |
| Q1 2022 | $2,263,000 | -68.8% | 3,152,758 | -1.7% | 0.00% | -100.0% |
| Q4 2021 | $7,250,000 | -22.1% | 3,207,989 | -0.7% | 0.00% | 0.0% |
| Q3 2021 | $9,302,000 | -16.0% | 3,229,943 | +10.5% | 0.00% | -50.0% |
| Q2 2021 | $11,076,000 | +25.9% | 2,922,652 | +12.5% | 0.00% | +100.0% |
| Q1 2021 | $8,796,000 | +41.2% | 2,598,807 | +16.8% | 0.00% | 0.0% |
| Q4 2020 | $6,228,000 | +15.1% | 2,224,571 | +3.2% | 0.00% | 0.0% |
| Q3 2020 | $5,412,000 | -81.0% | 2,156,618 | +2.6% | 0.00% | -83.3% |
| Q2 2020 | $28,540,000 | +106.3% | 2,101,709 | +15.2% | 0.01% | +50.0% |
| Q1 2020 | $13,831,000 | -34.0% | 1,824,766 | -45.0% | 0.00% | +100.0% |
| Q4 2019 | $20,954,000 | +238.6% | 3,315,656 | +110.0% | 0.00% | +100.0% |
| Q3 2019 | $6,188,000 | -14.7% | 1,578,822 | +5.3% | 0.00% | -50.0% |
| Q2 2019 | $7,255,000 | -29.9% | 1,499,093 | +18.6% | 0.00% | -33.3% |
| Q1 2019 | $10,353,000 | -7.4% | 1,264,319 | -37.5% | 0.00% | +50.0% |
| Q4 2018 | $11,186,000 | +98.6% | 2,023,088 | +217.1% | 0.00% | 0.0% |
| Q3 2018 | $5,633,000 | -3.6% | 637,950 | +9.0% | 0.00% | 0.0% |
| Q2 2018 | $5,842,000 | +11.4% | 585,394 | +6.4% | 0.00% | 0.0% |
| Q1 2018 | $5,242,000 | -29.7% | 550,235 | +9.8% | 0.00% | -33.3% |
| Q4 2017 | $7,453,000 | -31.8% | 501,263 | -9.8% | 0.00% | -25.0% |
| Q3 2017 | $10,934,000 | +131.9% | 555,917 | +69.4% | 0.00% | +100.0% |
| Q2 2017 | $4,715,000 | +55.3% | 328,181 | -0.6% | 0.00% | +100.0% |
| Q1 2017 | $3,036,000 | -7.4% | 330,096 | +4.7% | 0.00% | -50.0% |
| Q4 2016 | $3,280,000 | +17.5% | 315,137 | +2.2% | 0.00% | +100.0% |
| Q3 2016 | $2,791,000 | +63.4% | 308,405 | +35.0% | 0.00% | 0.0% |
| Q2 2016 | $1,708,000 | -14.0% | 228,369 | +3.5% | 0.00% | 0.0% |
| Q1 2016 | $1,987,000 | +4.9% | 220,579 | +50.4% | 0.00% | 0.0% |
| Q4 2015 | $1,895,000 | +53.7% | 146,708 | +14.9% | 0.00% | 0.0% |
| Q3 2015 | $1,233,000 | -1.5% | 127,691 | +4.9% | 0.00% | 0.0% |
| Q2 2015 | $1,252,000 | +162.5% | 121,759 | +183.6% | 0.00% | – |
| Q1 2015 | $477,000 | +1.7% | 42,938 | +6.6% | 0.00% | – |
| Q4 2014 | $469,000 | -41.2% | 40,298 | +11.9% | 0.00% | -100.0% |
| Q3 2014 | $797,000 | -4.1% | 36,019 | +20.4% | 0.00% | 0.0% |
| Q2 2014 | $831,000 | – | 29,911 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |